John Leonard, MD is the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology at Weill Cornell Medical College in New York City. He spoke with Oncology Data Advisor at the 2016 Asheville Hematologic Malignancies Symposium about optimizing therapeutic approaches for mantle cell lymphoma in the context of limited randomized trial data and tips for counseling patients about their disease and its treatment.

Discussion Notes: On treatment planning in the context of limited randomized trial data [1:15] On the unique challenges of treating MCL compared with other lymphomas [2:43] On counseling patients about their treatment experience [4:13]